588 related articles for article (PubMed ID: 21145849)
1. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.
Begriche K; Massart J; Robin MA; Borgne-Sanchez A; Fromenty B
J Hepatol; 2011 Apr; 54(4):773-94. PubMed ID: 21145849
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial involvement in drug-induced liver injury.
Pessayre D; Mansouri A; Berson A; Fromenty B
Handb Exp Pharmacol; 2010; (196):311-65. PubMed ID: 20020267
[TBL] [Abstract][Full Text] [Related]
3. Central role of mitochondria in drug-induced liver injury.
Pessayre D; Fromenty B; Berson A; Robin MA; Lettéron P; Moreau R; Mansouri A
Drug Metab Rev; 2012 Feb; 44(1):34-87. PubMed ID: 21892896
[TBL] [Abstract][Full Text] [Related]
4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies.
Labbe G; Pessayre D; Fromenty B
Fundam Clin Pharmacol; 2008 Aug; 22(4):335-53. PubMed ID: 18705745
[TBL] [Abstract][Full Text] [Related]
6. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
[TBL] [Abstract][Full Text] [Related]
7. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
[TBL] [Abstract][Full Text] [Related]
8. [Mitochondria and hepatotoxicity of ethanol].
Teplova VV; Belosludtsev KN; Belosludtseva NV; Kholmukhamedov EL
Biofizika; 2010; 55(6):1038-47. PubMed ID: 21268348
[TBL] [Abstract][Full Text] [Related]
9. Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.
López-Pascual E; Rienda I; Perez-Rojas J; Rapisarda A; Garcia-Llorens G; Jover R; Castell JV
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791241
[TBL] [Abstract][Full Text] [Related]
10. Microvesicular steatosis induced by a short chain fatty acid: effects on mitochondrial function and correlation with gene expression.
Jolly RA; Ciurlionis R; Morfitt D; Helgren M; Patterson R; Ulrich RG; Waring JF
Toxicol Pathol; 2004; 32 Suppl 2():19-25. PubMed ID: 15503661
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence?
García-Ruiz C; Baulies A; Mari M; García-Rovés PM; Fernandez-Checa JC
Free Radic Res; 2013 Nov; 47(11):854-68. PubMed ID: 23915028
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
Begriche K; Massart J; Robin MA; Bonnet F; Fromenty B
Hepatology; 2013 Oct; 58(4):1497-507. PubMed ID: 23299992
[TBL] [Abstract][Full Text] [Related]
13. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
14. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.
Flamment M; Arvier M; Gallois Y; Simard G; Malthièry Y; Ritz P; Ducluzeau PH
Biochimie; 2008 Sep; 90(9):1407-13. PubMed ID: 18534199
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Potential Risk of Drugs to Induce Hepatotoxicity in Human-Relationships between Hepatic Steatosis Observed in Non-Clinical Toxicity Study and Hepatotoxicity in Humans.
Goda K; Kobayashi A; Takahashi A; Takahashi T; Saito K; Maekawa K; Saito Y; Sugai S
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417920
[TBL] [Abstract][Full Text] [Related]
16. Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function.
Valdecantos MP; Pérez-Matute P; González-Muniesa P; Prieto-Hontoria PL; Moreno-Aliaga MJ; Martínez JA
J Nutr Biochem; 2012 Dec; 23(12):1676-84. PubMed ID: 22464149
[TBL] [Abstract][Full Text] [Related]
17. Hepatotoxicity due to mitochondrial dysfunction.
Pessayre D; Mansouri A; Haouzi D; Fromenty B
Cell Biol Toxicol; 1999; 15(6):367-73. PubMed ID: 10811531
[TBL] [Abstract][Full Text] [Related]
18. [Study of the morphological and metabolic effects of alcohol on liver].
Lieber CS; Rubin E; Decarli LM; Joly JG
Rev Med Chir Mal Foie; 1971; 46(6):233-54. PubMed ID: 4948888
[No Abstract] [Full Text] [Related]
19. Butyrate Regulates Liver Mitochondrial Function, Efficiency, and Dynamics in Insulin-Resistant Obese Mice.
Mollica MP; Mattace Raso G; Cavaliere G; Trinchese G; De Filippo C; Aceto S; Prisco M; Pirozzi C; Di Guida F; Lama A; Crispino M; Tronino D; Di Vaio P; Berni Canani R; Calignano A; Meli R
Diabetes; 2017 May; 66(5):1405-1418. PubMed ID: 28223285
[TBL] [Abstract][Full Text] [Related]
20. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.
Koliaki C; Roden M
Mol Cell Endocrinol; 2013 Oct; 379(1-2):35-42. PubMed ID: 23770462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
